BNR — Burning Rock Biotech Share News
0.000.00%
Last trade - 00:00- $164.08m
- $102.06m
- CNY539.57m
China's Burning Rock Biotech Q1 revenue falls on lower test volumes
China's Burning Rock Biotech Q4 net loss narrows as costs fall
Cancer diagnostics firm Burning Rock Biotech's Q3 revenue rises on pharma R&D growth
Brief: Burning Rock's Oncoguide™ Oncoscreen™ Plus CDX System Now Approved In Japan As A Companion Diagnostic For Capivasertib In Breast Cancer
Brief: Burning Rock Reports Qtrly class a ordinary shares says basic and diluted loss RMB 0.35
Brief: Burning Rock Announces Changes To Management And Board Of Directors
Burning Rock Biotech - BNR Reports Second Quarter 2024 Financial Results
Brief: Burning Rock Biotech Announces Expected Delisting Of American Depositary Shares
Brief: Burning Rock Currently Expect To Achieve Breakeven For Full Year 2024
Burning Rock Biotech - 1st Quarter Results
Burning Rock Biotech - BNR Schedules 2024 Q1 Earnings Release on May 29
Brief: Burning Rock Announces ADS Ratio Change To Be Effective On May 15, 2024
Burning Rock Biotech - BNR Announces ADS Ratio Change to Be Effective
Burning Rock Biotech - BNR Reports 23Q4 and Full Year Financial Results
Brief: Burning Rock Biotech Announces Receipt Of Notification From Nasdaq
Burning Rock Biotech - BNR Announces Receipt of Notification from NASDAQ
Brief: Burning Rock Announces Receipt Of Notification From Nasdaq
Burning Rock Biotech - BNR Reports Third Quarter 2023 Financial Results
Brief: Burning Rock Says Qtrly Loss Per Share $0.23